Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders

This study is currently recruiting participants.

Verified by Norwegian University of Science and Technology, April 2008

First Received: October 31, 2005 Last Updated: April 10, 2008 History of Changes

Sponsored by:	Norwegian University of Science and Technology
Information provided by:	Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:	NCT00247234

Purpose

This study intends to compare the effectiveness of schema therapy with standard psychiatric outpatient care for patients with borderline or avoidant personality disorder.

Condition	Intervention	Phase
Personality Disorder, Borderline Avoidant Personality Disorder	Behavioral: Schema Therapy	Phase II

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Single Group Assignment
Official Title:	Effectiveness of Group Based Schema Therapy in the Treatment of Borderline Personality Disorder and Effectiveness of Group Based Schema Therapy in the Treatment of Avoidant Personality Disorder

Resource links provided by NLM:

MedlinePlus related topics: Personality Disorders

U.S. FDA Resources

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:

Self-report measures of:
quality of life
depression
anxiety
suicidal ideation
interpersonal function

Secondary Outcome Measures:

Number of diagnostic criteria (reSCID)
Drop-out rate
Social adjustment
Use of psychotropic medication

Estimated Enrollment:	96
Study Start Date:	September 2004

Eligibility

Ages Eligible for Study:	20 Years to 50 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Avoidant or Borderline personality disorders

Exclusion Criteria:

Do not speak Scandinavian languages
Antisocial personality disorder
Narcissistic personality disorder
Affective bipolar disorder I
Schizophrenia
Mental impairment/organic brain disorder
Substance dependence
Planned pregnancy
Serious somatic illness
Anorexia Nervosa

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00247234

Contacts

Contact: Gunilla K. Fosse	+47 90 13 73 76	gunilla.fosse@ntnu.no
Contact: Are Holen	+47 73 55 15 13	are.holen@ntnu.no

Locations

Norway
St. Olavs Hospital	Recruiting
Trondheim, Norway, 7030
Contact: Gunilla K. Fosse, M.D. +47 13 73 76 gunilla.fosse@ntnu.no
Contact: Are Holen, M.D., Ph.D. +47 73 55 15 13 are.holen@ntnu.no

Sponsors and Collaborators

Norwegian University of Science and Technology

Investigators

Study Chair:

Are Holen, M.D., Ph.D.

Department of Neuroscience, NTNU - Faculty of Medicine, MTFS, NO-7489 Trondheim, Norway

More Information

No publications provided

Study ID Numbers:	ursula.falkmer+AEA-stolav.no
Study First Received:	October 31, 2005
Last Updated:	April 10, 2008
ClinicalTrials.gov Identifier:	NCT00247234 History of Changes
Health Authority:	Norway: The National Committees for Research Ethics in Norway

Study placed in the following topic categories:

Mental Disorders
Borderline Personality Disorder
Personality Disorders

Additional relevant MeSH terms:

Pathologic Processes
Disease
Mental Disorders
Borderline Personality Disorder
Personality Disorders

ClinicalTrials.gov processed this record on September 10, 2009